KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

BeOne Medicines (ONC) Other Gross PP&E Adjustments: 2015-2025

Historic Other Gross PP&E Adjustments for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to $1.7 billion.

  • BeOne Medicines' Other Gross PP&E Adjustments rose 197.63% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 billion, marking a year-over-year increase of 655.59%. This contributed to the annual value of $491.8 million for FY2024, which is 1752.62% up from last year.
  • Latest data reveals that BeOne Medicines reported Other Gross PP&E Adjustments of $1.7 billion as of Q3 2025, which was up 41.27% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Other Gross PP&E Adjustments registered a high of $1.7 billion during Q3 2025, and its lowest value of -$29.8 million during Q4 2023.
  • In the last 3 years, BeOne Medicines' Other Gross PP&E Adjustments had a median value of $250.8 million in 2023 and averaged $464.3 million.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first crashed by 116.73% in 2024, then surged by 4,545.86% in 2025.
  • Over the past 5 years, BeOne Medicines' Other Gross PP&E Adjustments (Quarterly) stood at $205.8 million in 2021, then skyrocketed by 46.02% to $300.5 million in 2022, then crashed by 109.90% to -$29.8 million in 2023, then spiked by 1,752.62% to $491.8 million in 2024, then surged by 197.63% to $1.7 billion in 2025.
  • Its last three reported values are $1.7 billion in Q3 2025, $1.2 billion for Q2 2025, and $696.6 million during Q1 2025.